Hunan Junxin Environmental Protection (301109.SZ) published its post-hearing information pack for the H-share issuance.
Junxin Environmental Protection (301109.SZ) announced that the company is in the process of applying for the issuance of overseas-listed foreign shares (H shares) and listing on the Main Board of The Stock Exchange of Hong Kong Limited. On August 13, 2026, the Listing Committee of the Hong Kong Stock Exchange held a listing hearing to review the company's application for this issuance and listing. According to the timetable for this issuance and listing, the company has published the post-hearing information pack for this issuance and listing on the Hong Kong Stock Exchange website in accordance with relevant regulations.
Hunan Junxin Environmental Protection (301109.SZ) announced that the company is carrying out the relevant work for its application to issue overseas-listed foreign shares (H shares) and to list on the Main Board of The Stock Exchange of Hong Kong Limited. On August 13, 2026, the Listing Committee of the Hong Kong Stock Exchange held a listing hearing to review the company's application for this issuance and listing. According to the timetable for this issuance and listing, the company has published the post-hearing information pack for this issuance and listing on the website of the Hong Kong Stock Exchange in accordance with relevant regulations.
Related Articles
A-share Midday | Shanghai Composite Index Rises 0.16%, Lab-grown Diamond and MLCC Concepts Strengthen Collectively
GEELY AUTO (00175) issues 20,000 shares upon exercise of share options.
HK Stock Market Move | CARSGEN-B (02171) rose nearly 3% in the morning as the FNC lymphodepletion preconditioning regimen received formal patent authorization in China.
A-share Midday | Shanghai Composite Index Rises 0.16%, Lab-grown Diamond and MLCC Concepts Strengthen Collectively
GEELY AUTO (00175) issues 20,000 shares upon exercise of share options.
HK Stock Market Move | CARSGEN-B (02171) rose nearly 3% in the morning as the FNC lymphodepletion preconditioning regimen received formal patent authorization in China.
RECOMMEND
